Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc - The Niche
The path to the clinic is a slow arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies
Professor Paul Knoepfler, Ph.D.
